China Medical System Holdings Resultados de beneficios anteriores

Pasado controles de criterios 2/6

China Medical System Holdings ha aumentado sus beneficios a una tasa media anual de 11%, mientras que los beneficios de la industria de Pharmaceuticals han experimentado un crecimiento de 5.9% anual. Los ingresos han ido creciendo a una tasa media de 11% al año. La rentabilidad financiera de China Medical System Holdings es de 15.3%, y sus márgenes netos son de 30%.

Información clave

11.0%

Tasa de crecimiento de los beneficios

11.3%

Tasa de crecimiento del BPA

Crecimiento de la industria Pharmaceuticals	5.6%
Tasa de crecimiento de los ingresos	11.0%
Rentabilidad financiera	15.3%
Margen neto	30.0%
Última actualización de beneficios	31 Dec 2023

Actualizaciones de resultados anteriores recientes

Recent updates

We Think Shareholders May Want To Consider A Review Of China Medical System Holdings Limited's (HKG:867) CEO Compensation Package

May 02

China Medical System Holdings' (HKG:867) Shareholders Will Receive A Smaller Dividend Than Last Year

Apr 19

China Medical System Holdings (HKG:867) Is Paying Out Less In Dividends Than Last Year

Mar 29

Not Many Are Piling Into China Medical System Holdings Limited (HKG:867) Stock Yet As It Plummets 35%

Mar 28

China Medical System Holdings Limited's (HKG:867) Share Price Not Quite Adding Up

Dec 21

Is China Medical System Holdings (HKG:867) A Risky Investment?

Dec 04

If EPS Growth Is Important To You, China Medical System Holdings (HKG:867) Presents An Opportunity

Nov 15

China Medical System Holdings (HKG:867) Will Pay A Larger Dividend Than Last Year At CN¥0.342

Aug 31

China Medical System Holdings (HKG:867) Could Easily Take On More Debt

Aug 30

Here's Why We Think China Medical System Holdings (HKG:867) Might Deserve Your Attention Today

Aug 07

We Think China Medical System Holdings (HKG:867) Can Manage Its Debt With Ease

May 14

Does China Medical System Holdings (HKG:867) Deserve A Spot On Your Watchlist?

Apr 26

An Intrinsic Calculation For China Medical System Holdings Limited (HKG:867) Suggests It's 47% Undervalued

Feb 05

China Medical System Holdings (HKG:867) Seems To Use Debt Rather Sparingly

Dec 26

If EPS Growth Is Important To You, China Medical System Holdings (HKG:867) Presents An Opportunity

Dec 08

Is China Medical System Holdings (HKG:867) Using Too Much Debt?

Sep 14

China Medical System Holdings (HKG:867) Is Paying Out A Larger Dividend Than Last Year

Aug 25

Do China Medical System Holdings' (HKG:867) Earnings Warrant Your Attention?

Aug 15

An Intrinsic Calculation For China Medical System Holdings Limited (HKG:867) Suggests It's 49% Undervalued

Jul 08

Should You Be Adding China Medical System Holdings (HKG:867) To Your Watchlist Today?

May 16

Does China Medical System Holdings (HKG:867) Have A Healthy Balance Sheet?

Apr 10

China Medical System Holdings (HKG:867) Is Increasing Its Dividend To HK$0.28

Mar 22

If You Like EPS Growth Then Check Out China Medical System Holdings (HKG:867) Before It's Too Late

Feb 09

Does China Medical System Holdings (HKG:867) Have A Healthy Balance Sheet?

Dec 25

Should You Be Adding China Medical System Holdings (HKG:867) To Your Watchlist Today?

Nov 10

China Medical System Holdings (HKG:867) Could Easily Take On More Debt

Sep 25

China Medical System Holdings' (HKG:867) Dividend Will Be Increased To HK$0.32

Aug 26

Here's Why We Think China Medical System Holdings (HKG:867) Is Well Worth Watching

Jul 30

An Intrinsic Calculation For China Medical System Holdings Limited (HKG:867) Suggests It's 33% Undervalued

Jun 27

China Medical System Holdings (HKG:867) Could Easily Take On More Debt

Jun 14

Does China Medical System Holdings (HKG:867) Deserve A Spot On Your Watchlist?

Apr 20

Is There An Opportunity With China Medical System Holdings Limited's (HKG:867) 43% Undervaluation?

Mar 25

Shareholders Are Loving China Medical System Holdings Limited's (HKG:867) 3.0% Yield

Mar 08

Here's What China Medical System Holdings Limited's (HKG:867) Shareholder Ownership Structure Looks Like

Feb 09

China Medical System Holdings' (HKG:867) Shareholders Are Down 45% On Their Shares

Jan 19

Is China Medical System Holdings Limited's (HKG:867) Latest Stock Performance Being Led By Its Strong Fundamentals?

Dec 30

Desglose de ingresos y gastos
Beta

Cómo gana y gasta dinero China Medical System Holdings. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).

Historial de beneficios e ingresos

SEHK:867 Ingresos, gastos y beneficios (CNY Millions)
Fecha	Ingresos	Beneficios	Gastos G+A	Gastos de I+D
31 Dec 23	8,013	2,401	3,168	195
30 Sep 23	8,663	2,891	3,313	170
30 Jun 23	9,313	3,381	3,457	146
31 Mar 23	9,232	3,320	3,408	136
31 Dec 22	9,150	3,259	3,358	125
30 Sep 22	9,046	3,224	3,347	129
30 Jun 22	8,942	3,189	3,336	133
31 Mar 22	8,640	3,103	3,159	124
31 Dec 21	8,337	3,017	2,981	115
30 Sep 21	8,009	2,948	2,782	94
30 Jun 21	7,681	2,878	2,583	73
31 Mar 21	7,313	2,704	2,444	70
31 Dec 20	6,946	2,530	2,304	67
30 Sep 20	6,582	2,300	2,198	63
30 Jun 20	6,217	2,070	2,092	60
31 Mar 20	6,145	2,015	2,119	53
31 Dec 19	6,074	1,961	2,145	45
30 Sep 19	5,908	2,011	2,103	30
30 Jun 19	5,743	2,062	2,060	15
31 Mar 19	5,588	1,956	1,988	8
31 Dec 18	5,433	1,850	1,916	0
30 Sep 18	5,375	1,839	1,829	0
30 Jun 18	5,317	1,827	1,743	0
31 Mar 18	5,333	1,751	1,674	0
31 Dec 17	5,349	1,675	1,604	0
30 Sep 17	5,379	1,601	1,566	0
30 Jun 17	5,410	1,527	1,529	0
31 Mar 17	5,155	1,452	1,462	0
31 Dec 16	4,901	1,376	1,395	0
30 Sep 16	4,477	1,265	1,259	0
30 Jun 16	4,054	1,155	1,123	0
31 Mar 16	3,804	1,075	1,065	0
31 Dec 15	3,553	996	1,007	0
30 Sep 15	3,404	1,062	957	0
30 Jun 15	3,255	1,128	908	0
31 Mar 15	3,100	1,087	845	0
31 Dec 14	2,945	1,046	783	0
30 Sep 14	2,760	890	729	0
30 Jun 14	2,575	734	676	0
31 Mar 14	2,412	685	644	0
31 Dec 13	2,249	636	613	0
30 Sep 13	2,081	603	568	0
30 Jun 13	1,961	584	535	0

Ingresos de calidad: 867 tiene ganancias de alta calidad.

Margen de beneficios creciente: Los actuales márgenes de beneficio(30%) de 867 son inferiores a los del año pasado (35.6%).

Análisis del flujo de caja libre vs. Beneficios

Análisis del crecimiento de los beneficios en el pasado

Tendencia de beneficios: Los beneficios de 867 han crecido un 11% al año en los últimos 5 años.

Acelerando crecimiento: 867 ha tenido un crecimiento negativo de los beneficios en el último año, por lo que no puede compararse con su media de 5 años.

Beneficios vs. Industria: 867 tuvo un crecimiento negativo de los beneficios (-26.3%) durante el año pasado, lo que dificulta la comparación con la media de la industria Pharmaceuticals (1.3%).

Rentabilidad financiera

Alta ROE: La rentabilidad financiera de 867 (15.3%) se considera baja.

China Medical System Holdings Resultados de beneficios anteriores

Pasado controles de criterios 2/6

Información clave

Actualizaciones de resultados anteriores recientes

Full year 2023 earnings: EPS and revenues miss analyst expectations

China Medical System Holdings Limited to Report Fiscal Year 2023 Results on Mar 27, 2024

First half 2023 earnings released: EPS: CN¥0.78 (vs CN¥0.73 in 1H 2022)

China Medical System Holdings Limited to Report First Half, 2023 Results on Aug 28, 2023

Full year 2022 earnings released: EPS: CN¥1.33 (vs CN¥1.22 in FY 2021)

First half 2022 earnings released: EPS: CN¥0.73 (vs CN¥0.66 in 1H 2021)

Recent updates

We Think Shareholders May Want To Consider A Review Of China Medical System Holdings Limited's (HKG:867) CEO Compensation Package

Now 21% undervalued after recent price drop

China Medical System Holdings Limited Announces New Drug Application of Desidustat Tablets Accepted in China

China Medical System Holdings' (HKG:867) Shareholders Will Receive A Smaller Dividend Than Last Year

Now 21% undervalued after recent price drop

Consensus revenue estimates decrease by 18%

China Medical System Holdings Limited Proposes Final Dividend for the Year Ended 31 December 2023, Payable on About 23 May 2024

China Medical System Holdings (HKG:867) Is Paying Out Less In Dividends Than Last Year

Final dividend of HK$0.086 announced

Not Many Are Piling Into China Medical System Holdings Limited (HKG:867) Stock Yet As It Plummets 35%

China Medical System Holdings Limited, Annual General Meeting, May 09, 2024

Full year 2023 earnings: EPS and revenues miss analyst expectations

Now 38% undervalued after recent price drop

China Medical System Holdings Limited Proposes Final Dividend for the Year Ended 31 December 2023, Payable on About 23 May 2024

China Medical System Holdings Limited Announces Approval to Conduct A Phase 3 Clinical Trial Investigating Ruxolitinib Cream in Atopic Dermatitis in China

China Medical System Holdings Limited to Report Fiscal Year 2023 Results on Mar 27, 2024

China Medical System Holdings Limited's (HKG:867) Share Price Not Quite Adding Up

China Medical System Holdings Limited Announces Approval to Conduct a Phase 3 Clinical Trial Investigating Ruxolitinib Cream in Vitiligo in China

China Medical System Holdings Limited Announces That on 4 December 2023, the New Drug Application (Nda) for an Additional Indication of Methotrexate Injection Has Been Accepted by the National Medical Products Administration of China

Is China Medical System Holdings (HKG:867) A Risky Investment?

If EPS Growth Is Important To You, China Medical System Holdings (HKG:867) Presents An Opportunity

Upcoming dividend of HK$0.34 per share at 5.1% yield

China Medical System Holdings (HKG:867) Will Pay A Larger Dividend Than Last Year At CN¥0.342

First half 2023 earnings released: EPS: CN¥0.78 (vs CN¥0.73 in 1H 2022)

China Medical System Holdings (HKG:867) Could Easily Take On More Debt

China Medical System Holdings Limited Announces Interim Dividend for the Six Months Ended June 30, 2023, Payable on September 20, 2023

China Medical System Holdings Limited to Report First Half, 2023 Results on Aug 28, 2023

Here's Why We Think China Medical System Holdings (HKG:867) Might Deserve Your Attention Today

China Medical System Holdings Limited Receives Approval from National Medical Products Administration of China for New Drug Application of Diazepam Nasal Spray

National Medical Products Administration of China Approves China Medical System Holdings's New Drug Application of Tildrakizumab Injection under the Brand Name of ILUMETRI

We Think China Medical System Holdings (HKG:867) Can Manage Its Debt With Ease

Upcoming dividend of HK$0.27 per share at 4.5% yield

Does China Medical System Holdings (HKG:867) Deserve A Spot On Your Watchlist?

Full year 2022 earnings released: EPS: CN¥1.33 (vs CN¥1.22 in FY 2021)

China Medical System Holdings Limited Announces New Drug Application of Methylthioninium Chloride Enteric-Coated Sustained-Release Tablets

An Intrinsic Calculation For China Medical System Holdings Limited (HKG:867) Suggests It's 47% Undervalued

China Medical System Holdings (HKG:867) Seems To Use Debt Rather Sparingly

China Medical System Holdings Limited Announces its Methylthioninium Chloride Enteric-Coated Sustained-Release Tablets Obtains Positive Results for its Phase III Clinical Trial in China

If EPS Growth Is Important To You, China Medical System Holdings (HKG:867) Presents An Opportunity

Investor sentiment improved over the past week

Is China Medical System Holdings (HKG:867) Using Too Much Debt?

Upcoming dividend of HK$0.34 per share

China Medical System Holdings (HKG:867) Is Paying Out A Larger Dividend Than Last Year

First half 2022 earnings released: EPS: CN¥0.73 (vs CN¥0.66 in 1H 2021)

China Medical System Holdings Limited Announces Interim Dividend for the Six Months Ended June 30, 2022, Payable on 15 September 2022

Do China Medical System Holdings' (HKG:867) Earnings Warrant Your Attention?

China Medical System Holdings Limited to Report First Half, 2022 Results on Aug 22, 2022

An Intrinsic Calculation For China Medical System Holdings Limited (HKG:867) Suggests It's 49% Undervalued

Should You Be Adding China Medical System Holdings (HKG:867) To Your Watchlist Today?

China Medical System Holdings Limited Approves Final Dividend for the Year Ended December 31, 2021

Upcoming dividend of HK$0.28 per share

Does China Medical System Holdings (HKG:867) Have A Healthy Balance Sheet?

Full year 2021 earnings: EPS in line with analyst expectations despite revenue beat

China Medical System Holdings (HKG:867) Is Increasing Its Dividend To HK$0.28

Full year 2021 earnings: EPS in line with analyst expectations despite revenue beat

Investor sentiment deteriorated over the past week

China Medical System Holdings Limited to Report Fiscal Year 2021 Results on Mar 15, 2022

If You Like EPS Growth Then Check Out China Medical System Holdings (HKG:867) Before It's Too Late

Does China Medical System Holdings (HKG:867) Have A Healthy Balance Sheet?

China Medical System Holdings Limited Announces New Drug Application of Methotrexate Injection, Pre-Filled Syringe Accepted in China

Should You Be Adding China Medical System Holdings (HKG:867) To Your Watchlist Today?

Independent Non-Executive Director Chi Keung Wu has left the company

China Medical System Holdings Limited Establishes A New Programme with XF-73 Targeting the Prevention and Treatment of Superficial Skin Infections Caused by Bacteria

China Medical System Holdings (HKG:867) Could Easily Take On More Debt

Upcoming dividend of HK$0.32 per share

China Medical System Holdings' (HKG:867) Dividend Will Be Increased To HK$0.32

First half 2021 earnings released: EPS CN¥0.66 (vs CN¥0.52 in 1H 2020)

National Medical Products Grants Approval to China Medical System Holdings Limited's Methotrexate Injection, Pre-Filled Syringe

China Medical System Holdings Limited Receives Approval for Innovative Patented Drug Methylthioninium Chloride Enteric-Coated Sustained-Release Tablets

Desglose de ingresos y gastos
Beta